Aspen Grove Capital’s VanEck Biotech ETF BBH Stock Holding History

Aspen Grove Capital’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$925K	Sell	4,919 -2,519	-34%	-$485K	0.18%	73
2025 Q4	$1.41M	Sell	7,438 -2,540	-25%	-$470K	0.24%	56
2025 Q3	$1.65M	Hold	9,978	–	–	0.28%	51
2025 Q2	$1.53M	Hold	9,978	–	–	0.26%	54
2025 Q1	$1.57M	Hold	9,978	–	–	0.3%	51
2024 Q4	$1.57M	Buy	9,978 +78	+0.8%	+$13.1K	0.33%	50
2024 Q3	$1.76M	Hold	9,900	–	–	0.39%	42
2024 Q2	$1.67M	Hold	9,900	–	–	0.39%	43
2024 Q1	$1.65M	Hold	9,900	–	–	0.47%	42
2023 Q4	$1.64M	Buy	9,900 +43	+0.4%	+$6.62K	0.5%	41
2023 Q3	$1.53M	Hold	9,857	–	–	0.57%	37
2023 Q2	$1.54M	Hold	9,857	–	–	0.5%	41
2023 Q1	$1.6M	Hold	9,857	–	–	0.7%	30
2022 Q4	$1.57M	Buy	+9,857	New	+$1.56M	0.73%	31

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Aspen Grove Capital's BBH Position: Q1 2026 in Review

Aspen Grove Capital reduced its VanEck Biotech ETF (BBH) stake by 34% in Q1 2026, selling an estimated $485K and leaving 4,919 shares worth $925K. The position accounts for 0.18% of the portfolio, ranked #73.

Aspen Grove Capital first reported a position in BBH in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.76M in Q3 2024. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Aspen Grove Capital held 4,919 shares of VanEck Biotech ETF worth $925K as of Q1 2026.
Aspen Grove Capital sold 2,519 VanEck Biotech ETF shares in Q1 2026, an estimated $485K.
VanEck Biotech ETF made up 0.18% of Aspen Grove Capital's portfolio in Q1 2026, its #73 holding.
Aspen Grove Capital first reported a position in VanEck Biotech ETF in Q4 2022 and has held it in 14 quarters since.
Aspen Grove Capital's VanEck Biotech ETF position peaked at $1.76M in Q3 2024.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Aspen Grove Capital's 13F filing for Q1 2026, filed 14 May 2026.